Inpart

Download our Partnering 2030 report! Based on our surveys with hundreds of biotechs, out-licensors, and research institutes, this is the industry's best guide to the challenges of partnering with top pharma firms and VC investors. 🔽 Secure your copy: eu1.hubs.ly/H0gglPm0

Connect Campaign 🔥💡 @group_icl is seeking academic and startup collaborations to advance a broad range of flame retardant (FR) materials. Read their campaign brief here 👉 eu1.hubs.ly/H0hKKBV0 #techtransfer #openinnovation #flameretardant #firesafety

New Connect campaign 🔥💡 @group_icl is seeking opportunities and innovation from research institutes and startups to advance novel flame retardants. Read their campaign brief here 👉 eu1.hubs.ly/H0hdfkl0 #techtransfer #flameretardant #firesafety

🌟 25 top innovations for 2025! 🌟 Discover the technologies that received the most engagement from industry on Connect in 2024, and are set to make the biggest impact in 2025: eu1.hubs.ly/H0glRs40 #topinnovations #biopharmainnovation

📰 New article | Life science CRM for the times: Why biopharma are seeking an end-to-end partnering platform Read more! eu1.hubs.ly/H0grbzh0 #lifesciencecrm #crm #partnering

🌊 Collaboration between academia and industry accelerates the journey from ideas to impactful technologies. We’ve highlighted the top 25 innovations from Connect that received the most engagement in 2024 from global R&D teams. Read the full article: eu1.hubs.ly/H0g6YNM0

Download our Partnering 2030 report! Based on our surveys with hundreds of biotechs, out-licensors, and research institutes, this is the industry's best guide to the challenges of partnering with top pharma firms and VC investors. 🔽 Secure your copy: eu1.hubs.ly/H0g40QY0

🌟@IN_PART's latest article surfaces the 25 top #innovations set to make waves in science R&D in 2025, and we are thrilled to have one of our technologies featured! Read the full article to learn more: bit.ly/4gVtzOl #TechTransfer @UofGResearch @WCVMToday @OntVetCollege

📰 New article | Life science CRM for the times: Why biopharma are seeking an end-to-end partnering platform Read more! eu1.hubs.ly/H0f_Sdm0 #lifesciencecrm #crm #partnering

🌊 Collaboration between academia and industry accelerates the journey from ideas to impactful technologies. We’ve highlighted the top 25 innovations from Connect that received the most engagement in 2024 from global R&D teams. Read the full article: eu1.hubs.ly/H0fWm6z0

Are you ready for a new year of partnering? Join Inpart and @DealForma's Chris Dokomajilar to unpack the biopharma dealmaking trends of 2024 and predict the transformations that will emerge in 2025. Reserve your seat: eu1.hubs.ly/H0f-QLn0 #biopharmadealmaking

Download our Partnering 2030 report! Based on our surveys with hundreds of biotechs, out-licensors, and research institutes, this is the industry's best guide to the challenges of partnering with top pharma firms and VC investors. 🔽 Secure your copy: eu1.hubs.ly/H0fWc8w0

🎆 Our top 25 innovations for 2025 article highlights groundbreaking technologies on Connect with potential to reshape industries. Find it here: eu1.hubs.ly/H0fTwQp0 #topinnovations #techtransfer #openinnovation

Are you ready for a new year of partnering? Join Inpart and @DealForma's Chris Dokomajilar to unpack the biopharma dealmaking trends of 2024 and predict the transformations that will emerge in 2025. Reserve your seat: eu1.hubs.ly/H0fRFS-0 #biopharmadealmaking

🌍 We’re kicking off 2025 with our annual list of top innovations set to have the biggest impact across science and R&D in the coming year! These are the opportunities that captured the most engagement from industry in 2024. 🚀 Check out the article 👉 eu1.hubs.ly/H0fJtP90

Are you ready for a new year of partnering? Join Inpart and @DealForma's Chris Dokomajilar to unpack the biopharma dealmaking trends of 2024 and predict the transformations that will emerge in 2025. Reserve your seat: eu1.hubs.ly/H0fGSCm0 #biopharmadealmaking

Here’s to an incredible year at Inpart connecting scientific teams bringing groundbreaking innovations to life! 🎇 This year, we’ve initiated over 3,400 new conversations, with our network growing to over 20,000 scientific decision-makers and 9,000 active projects 🚀✨

Inpart connects academic institutes, researchers, companies and investors in an online network to unlock the power of science through partnering. To learn what can be solved through online scientific matchmaking, watch this video featuring Patrick Speedie, Inpart’s CBO. 🚀

We’re welcoming @LurieChildrens to Inpart Connect! ✨ 🧑‍🧬 Their portfolio of opportunities seeking industry partners include stem cell therapy for bladder regeneration and a novel RNA therapeutic for fibrotic disease. Find out more: eu1.hubs.ly/H0fvjZl0 #pedriatriccare

We’re excited to welcome the @sciencetokyo_en to Inpart Connect! 🌟 🔬 Check out their opportunities available for co-development, including a new therapeutic for liver disease: eu1.hubs.ly/H0fvdyD0 #techtransfer #openinnovation